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Abstract
Herbal medicines are a melee of complex organic chemicals, making it difficult to ascertain their direct
mechanism of action. In contrast to mainstream pharmaceuticals, it is argued that herbal medicines are
effective because of multiple constituents working synergistically. The complexity of herbal medicines
may give them advantages over simpler pharmaceuticals in combating antibiotic resistant microbes, but
these advantages can be difficult to quantitate. Popular literature frequently espouses the healing
properties of herbal medicines, but many of these claims are not scientifically supported. Many gains
could be realized in public health and medicine if more research was aimed at validating / disproving
commonly used remedies. “Home remedies” though scientifically unsupported may still be viable
treatments for certain diseases. Goldenseal (Hydrastis canadesis) is commonly used as an herbal therapy
to treat bacterial infections, particularly of the upper respiratory tract. In an attempt to provide an
organized investigation of weakly supported remedies, this research shows that extracts from
Goldenseal have a greater antibiotic effect than the alkaloid berberine, which is thought to be its
primary active compound. Minimal Inhibitory Concentration assays were performed with
Staphylococcus aureus and found that the MIC of Goldenseal extract is over 15 times lower than the MIC
of pure berberine. The increased bactericidal effect of the Goldenseal extract suggests synergistic effects
with other compounds in the extract. Elucidation of the synergistic elements of Goldenseal extract and
their mechanisms of action would be useful in creating novel methods of decreasing bacterial resistance
to antibiotics.

Introduction
Modern antibiotics struggle to check the rise of drug resistant infections, and new methods are needed
to combat resistant species of bacteria. As microbes develop increased levels of resistance, the medical
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community must have either new, often more toxic drugs, or creatively combat the microbial modes of
resistance by developing methods sufficiently different from the approaches already undertaken. One
approach is to target the very agencies by which bacteria are resistant to drugs. Efflux pumps such as
the ones in the major facilitator superfamily are one mechanism bacteria use to evade toxins (Marger,
1993). Inhibiting efflux pump activity may cause drugs to be retained in the cells longer, presenting the
opportunity for them to have a higher potential for lethality. Ironically, some antibiotics have been
shown to induce transcription of efflux systems leading directly to increased bacterial resistance
(Morita, 2006). Due to these complications, it would be beneficial to identify antimicrobial compounds
that target the activity of efflux systems directly, reducing the likelihood of contributing to drug
resistance.
Berberine, a secondary metabolite compound found in Hydrastis canadensis (Goldenseal), has been
shown to have antibiotic properties (Gentry, 1998; Hwang, 2003; Knight, 1999; Mahady 2003;
Scazzocchio, 2001). These properties appear more pronounced in leaf or root extracts when compared
to pure berberine (Ettefagh, 2011). This increased bioactivity has been suggested to be due to
contemporary substances working synergistically with berberine (Gentry, 1998; Hwang, 2003; Knight,
1999; Mahady 2003; Scazzocchio, 2001). Specifically, these substances have been shown to inhibit
bacterial multidrug resistant efflux pumps such as the NorA pump (Stermitz, 2000). Efflux pump
inhibition allows berberine to remain in the cell longer, potentially increasing its bactericidal effect
(Ibid).
This study verifies a difference in antibacterial effect between pure berberine and whole Goldenseal
extracts that has been previously documented (Junio, 2011). A difference indicates that other
compounds than berberine alone are working to inhibit bacterial growth; such as inhibiting the
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bacteria’s drug efflux response. Whole plant extracts having an increased antibiotic effect suggests new
avenues of combating drug resistant bacterial species.

Hypothesis
Whole root extracts (defined in procedure) from Goldenseal will have a larger antibiotic effect on
Staphylococcus aureus than berberine alone as measured by 96 well plate MIC assay.

Materials and Methods
Extraction
The extracts were prepared by soaking liquid nitrogen powdered plant material for 24 hours in 5ml EtOH
per 1g plant material. Alcohol extracts were separated from remaining solids by suction filtration.

Detection of Berberine in Extract
The presence of berberine was detected via reverse phase HPLC with an Agilent technologies Eclipse
Plus C-18 column (4.6x150mm, 5µm) on an Agilent machine. The run was isocratic with 0.75 ml/min
with 70% 25mM ammonium formate pH 3.8 and 30% was 0.1% triethylamine with a column
temperature of 40 deg C, run for 13 minutes. Detection was performed at 230nm.

MIC Assay
Preparing 96 well plate
100ul of Mueller Hinton Broth was placed in each well of the plate. 100ul of extract to be tested was
placed in wells A2-A6. No extract was placed in the first well or last well because the first column (A1Department of Biology and Allied Health, Hickman Science Center, Southern Adventist University, Collegedale, TN 37315, USA; 352-658-3712;
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H1) was the positive control (broth with inoculum only) and the final column (A12-H12) served as the
negative control (broth only, no inoculum) respectively.
Two fold serial dilutions were performed with a 100ul multichannel pipet with 5 tips. 100ul of extract
from the first row was pipetted into the second row and aspirated a few times. Then 100ul was pipetted
from the second row to the third row and aspirated. This process was repeated to the last row and then
carried over to the second half of the plate.
In the same manner, a control plate was prepared with Berberine sulfate standard at 1mg/ml initial
concentration.

Inoculation
Initial broth to be tested was prepared from a 24 hour liquid culture.
Initial broth culture absorbance was read at 600nm and diluted with MHB until an optical density
matching 0.5 McFarland standard was achieved. 2ml of diluted culture was placed into 38ml sterile
water and vortexed. This dilution was used for inoculation. A 10ul multichannel pipette with 8 tips was
used to place 10ul of inoculum in each well, moving through columns instead of rows (A1-H1, A2-H2,
etc. Excluding final column as negative control).

Plate Count Confirmation of bacterial concentration
Within 15 minutes, plate count confirmation was performed by taking 10ul of inoculum placed into 10ml
of sterile saline and vortexed, then 100ul per plate was pipetted onto five MHA plates. Plates were
spread with cell spreader and allowed to dry before inverting and incubating.

Incubation
96 well plates were covered with autoclaved tin foil and incubated at 23 C° for 16-24 hours.
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MIC Determination
Plates were read with plate reader at 600nm and replicates were averaged. Minimum inhibitory
concentration was defined as the concentration in the first well that showed no significant difference in
turbidity from the control as suggested by error bars of 68% confidence on a bar graph.

Results
Berberine concentration in the Goldenseal root extracts (0.255 mg/mL) was determined from a standard
curve constructed from HPLC analysis of a concentration series of pure berberine. Peak area and
berberine concentration were found to be strongly linearly correlated (r2 = 0.9999). Peak height and
berberine concentration were also very strongly correlated, but by a second order polynomial
relationship. The linear relationship between peak area and berberine concentration was used to
construct the standard curve in Figure 1.
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Figure 1. Standard curve in the form of a linear regression showing correlation of berberine
concentration and peak area from HPLC chromatograms, N = 8 separate concentrations. Equation
of the line y = 0.1071x + 1.0707.
Minimum inhibitory concentration assays were performed for both berberine and Goldenseal whole
root extract. Minimum inhibitory dilution was determined as the lowest concentration treatment to
have no significant difference in absorbance before and after incubation (Figure 2). Dilution factor of the
minimum inhibitory dilution and original berberine concentration were used to determine the minimum
inhibitory concentration. MIC’s were compared to berberine concentration. MIC of berberine in the
standard (berberine alone) was 0.0156 mg/mL. MIC of berberine in the Goldenseal root extract was
0.000996 mg/mL.
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Figure 2. Difference in absorbance before and after incubation at 23°C for
16 hours. Minimum inhibitory dilution determined by the most dilute
treatment where no there is significant difference in absorbance post
incubation. In this case dilution 8 was the minimum inhibitory dilution. Error
bars represent standard error.
The MIC of Goldenseal whole root extract is 15.7 times lower than that of pure berberine alone
(Figure 3). HPLC and MIC data demonstrated that substantially less berberine is required in the
Goldenseal whole root extract in order to have the same inhibitory effect as pure berberine alone.
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Figure 3. Concentration of the alkaloid
berberine in MIC assays run with berberine
standard and Goldenseal root extract.

Discussion
Berberine has wide ranging mechanisms of lethality. The mechanisms for the bactericidal effect of
berberine include: inhibiting DNA duplication, RNA transcription, and protein biosynthesis; influencing
or inhibiting enzyme activities; destructing the bacterial cell surface structure and resulting in Ca2+ and
K+ released from cells (Pei-ji, et. Al.). All of berberine’s targets are necessary for cell survival, which
prohibits bacteria from developing resistance by simply mutating a lack of dependence on the berberine
target.
The more than ten-fold difference in berberine concentration necessary to achieve inhibition strongly
suggests the presence of another active compound in Goldenseal root extract. Berberine must not be
the only antimicrobial present. Likely, Goldenseal contains other antibiotic compounds, or more
interestingly, compounds which act synergistically with berberine.
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This study tested only Goldenseal whole root extracts. Ettefagh et. all found that aerial portions of
Goldenseal have a more pronounce synergistic effect. Synergy is observed in root extracts but is
substantially increased in extracts of aerial plant portions according to Ettefagh. Berberine is present in
highest concentrations in the roots of Goldenseal, but the leaves have more synergistic compounds
(Ettefagh et al). Further work in this area should include HPLC fractionation on the constituents of aerial
extracts. Fractions should be tested for synergistic effects and then their chemical identities elucidated.
The flavonoids sideroxylin, 8-desmethyl-sideroxylin and 6-desmethyl-sideroxylin have already been
shown to synergistically enhance the action of berberine (Junio et al). After such chemical elucidation,
studies could aim to determine the mechanism of action by examining constituents’ effects on the Nor A
efflux pump of Staphylococcus aureus. Ethidium bromide efflux inhibition has been observed due to
aerial Goldenseal extracts, but not for Staphylococcus aureus derivatives with Nor A deleted (Ettefagh et
al).
It is possible that a compound found primarily in aerial portions of the Goldenseal plant directly inhibits
the bacteria’s method of removing the antibiotic berberine from the cytosol. This would be an
important discovery because it is known that drug resistant bacteria upregulate their efflux pumps
(Brown et al). Understanding of the synergistic mechanism might give insight on how to design
antibiotics in ways that combat resistance.
Current pharmacological methodology is devoted to the production of highly specified single action
drugs. Goldenseal, if treated as a case study of natural pharmacy, might led credence to multimechanism approaches to drug use. Herbal remedies have long been used as broad spectrum
applications, often gaining repute from individuals of low intellectual esteem. Goldenseal is showing us
that the multi-mechanism action against disease is a valuable approach. Further formal study should be
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done on herbal remedies. Coupled with the intelligence of the scientific method, herbal remedies, and
lessons learned from herbal remedies, could revolutionize the way drugs are developed and deployed.
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